Article
Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes.
The Division of Diabetes and Metabolism, Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Diabetic Medicine (impact factor:
2.9).
07/2006;
23(6):617-22.
DOI:10.1111/j.1464-5491.2006.01849.x
pp.617-22
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
41 females
89 patients
atherosclerotic complications
carotid atherosclerosis
coronary artery diseases
hepatocyte growth factor
HGF correlated
intimal-media thickness
ischaemic heart disease
lacunar infarcts
multiple regression analysis
plaque score
Recent studies
risk factor
risk factors
serum HGF
Serum HGF concentration
standardized beta
Type 2 diabetes
Type 2 DM